Twin Disc, Inc. Announces Fiscal 2018 Second-Quarter Earnings Conference Call and Press Release
Jan 26, 2018 13:01 pm UTC| Business
RACINE, Wis., Jan. 26, 2018 -- Twin Disc, Inc. (NASDAQ:TWIN), today announced that it will release its fiscal 2018 second-quarter financial results before the market opens on Friday, February 2, 2018. In conjunction...
Medical-Grade Wearable Provider Biotricity Aims to Increase Patient Adherence
Jan 26, 2018 13:01 pm UTC| Business
REDWOOD CITY, Calif., Jan. 26, 2018 -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, is poised...
Future Farm Provides LED Canada Update
Jan 26, 2018 13:01 pm UTC| Business
Vancouver, British Columbia, Jan. 26, 2018 -- Future Farm Technologies Inc. (the “Company” or “Future Farm”) (CSE: FFT) (OTCQB: FFRMF) is pleased to announce that its LED Canada division has made significant progress in...
Premier Biomedical, Inc. CEO Letter -- January, 2018
Jan 26, 2018 13:01 pm UTC| Business
DALLAS, Jan. 26, 2018 -- Greetings From The CEO And Staff At Premier Biomedical! It has been a very busy and eventful quarter, and an exceptionally fruitful year, for Premier Biomedical (OTCQB:BIEI). Finance and...
Cuba Ventures Corp. Signs DA to Acquire Equity in United States Publisher of The Cuba Trade Magazine
Jan 26, 2018 13:01 pm UTC| Business
VANCOUVER, British Columbia, Jan. 26, 2018 -- Cuba Ventures Corp. (TSX-V:CUV) (Frankfurt:IJA2) (OTCBB:MPSFF) (the “Company”) – Media Division - is pleased to announce that it has signed a definitive agreement (“DA”) to...
Lakeland Bancorp Completes Sixth Consecutive Year of Record Earnings
Jan 26, 2018 13:01 pm UTC| Business
OAK RIDGE, N.J., Jan. 26, 2018 -- Lakeland Bancorp, Inc. (NASDAQ:LBAI) (the “Company”), the parent company of Lakeland Bank (“Lakeland”), reported net income and diluted earnings per share (“EPS”) of $13.2 million and...
Jan 26, 2018 13:00 pm UTC| Business
AUSTIN, Texas, Jan. 26, 2018 -- XBiotech Inc. (NASDAQ:XBIT) announced today additional data analysis of its Phase 2 study evaluating XBiotech’s True Human™ antibody, MABp1, as a treatment for Hidradenitis Suppurativa...